IRIS Accounts Production v24.1.4.33 07313450 Board of Directors Board of Directors 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh073134502022-11-30073134502023-11-30073134502022-12-012023-11-30073134502021-11-30073134502021-12-012022-11-30073134502022-11-3007313450ns15:EnglandWales2022-12-012023-11-3007313450ns14:PoundSterling2022-12-012023-11-3007313450ns10:Director12022-12-012023-11-3007313450ns10:Director22022-12-012023-11-3007313450ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3007313450ns10:SmallEntities2022-12-012023-11-3007313450ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3007313450ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3007313450ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3007313450ns10:FullAccounts2022-12-012023-11-3007313450ns10:RegisteredOffice2022-12-012023-11-3007313450ns5:CurrentFinancialInstruments2023-11-3007313450ns5:CurrentFinancialInstruments2022-11-3007313450ns5:ShareCapital2023-11-3007313450ns5:ShareCapital2022-11-3007313450ns5:RetainedEarningsAccumulatedLosses2023-11-3007313450ns5:RetainedEarningsAccumulatedLosses2022-11-3007313450ns5:ShortLeaseholdAssetsns5:LandBuildings2022-12-012023-11-3007313450ns5:PlantMachinery2022-12-012023-11-3007313450ns5:FurnitureFittings2022-12-012023-11-3007313450ns5:MotorVehicles2022-12-012023-11-3007313450ns5:ComputerEquipment2022-12-012023-11-3007313450ns5:ShortLeaseholdAssetsns5:LandBuildings2022-11-3007313450ns5:PlantMachinery2022-11-3007313450ns5:FurnitureFittings2022-11-3007313450ns5:ShortLeaseholdAssetsns5:LandBuildings2023-11-3007313450ns5:PlantMachinery2023-11-3007313450ns5:FurnitureFittings2023-11-3007313450ns5:ShortLeaseholdAssetsns5:LandBuildings2022-11-3007313450ns5:PlantMachinery2022-11-3007313450ns5:FurnitureFittings2022-11-3007313450ns5:MotorVehicles2022-11-3007313450ns5:ComputerEquipment2022-11-3007313450ns5:MotorVehicles2023-11-3007313450ns5:ComputerEquipment2023-11-3007313450ns5:MotorVehicles2022-11-3007313450ns5:ComputerEquipment2022-11-3007313450ns5:CostValuation2022-11-3007313450ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-3007313450ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-30
REGISTERED NUMBER: 07313450 (England and Wales)

















Pharmora Limited

Financial Statements

for the Year Ended 30 November 2023






Pharmora Limited (Registered number: 07313450)

Contents of the Financial Statements
for the year ended 30 November 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Pharmora Limited

Company Information
for the year ended 30 November 2023







DIRECTORS: Dr S J Pinches
I R Pinches





REGISTERED OFFICE: 24 Cornwall Road
Dorchester
Dorset
DT1 1RX





REGISTERED NUMBER: 07313450 (England and Wales)





ACCOUNTANTS: Read Woodruff
Chartered Accountants
24 Cornwall Road
Dorchester
Dorset
DT1 1RX

Pharmora Limited (Registered number: 07313450)

Balance Sheet
30 November 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 372,427 441,836
Investments 5 84 84
372,511 441,920

CURRENT ASSETS
Debtors 6 651,552 343,167
Cash at bank and in hand 209,137 78,338
860,689 421,505
CREDITORS
Amounts falling due within one year 7 754,271 499,768
NET CURRENT ASSETS/(LIABILITIES) 106,418 (78,263 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

478,929

363,657

PROVISIONS FOR LIABILITIES 13,787 21,898
NET ASSETS 465,142 341,759

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 465,140 341,757
SHAREHOLDERS' FUNDS 465,142 341,759

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 August 2024 and were signed on its behalf by:




Dr S J Pinches - Director



I R Pinches - Director


Pharmora Limited (Registered number: 07313450)

Notes to the Financial Statements
for the year ended 30 November 2023


1. STATUTORY INFORMATION

Pharmora Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Leasehold property - over the unexpired term of the lease
Plant and machinery - 20% on cost
Office equipment - 10% on cost
Motor vehicles - 20% on cost
Computer equipment - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2022 - 14 ) .

Pharmora Limited (Registered number: 07313450)

Notes to the Financial Statements - continued
for the year ended 30 November 2023


4. TANGIBLE FIXED ASSETS
Leasehold Plant and Office
property machinery equipment
£    £    £   
COST
At 1 December 2022 519,007 17,470 1,441
Additions 28,325 - 6,337
At 30 November 2023 547,332 17,470 7,778
DEPRECIATION
At 1 December 2022 130,943 17,470 784
Charge for year 99,108 - 397
At 30 November 2023 230,051 17,470 1,181
NET BOOK VALUE
At 30 November 2023 317,281 - 6,597
At 30 November 2022 388,064 - 657

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 December 2022 71,881 19,287 629,086
Additions 1,467 12,183 48,312
At 30 November 2023 73,348 31,470 677,398
DEPRECIATION
At 1 December 2022 26,356 11,697 187,250
Charge for year 14,425 3,791 117,721
At 30 November 2023 40,781 15,488 304,971
NET BOOK VALUE
At 30 November 2023 32,567 15,982 372,427
At 30 November 2022 45,525 7,590 441,836

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 December 2022
and 30 November 2023 84
NET BOOK VALUE
At 30 November 2023 84
At 30 November 2022 84

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 95,058 113,420
Amounts recoverable on contracts 267,409 227,309
Other debtors 289,085 2,438
651,552 343,167

Pharmora Limited (Registered number: 07313450)

Notes to the Financial Statements - continued
for the year ended 30 November 2023


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 287,630 180,448
Taxation and social security 241,586 143,356
Other creditors 225,055 175,964
754,271 499,768

8. OTHER FINANCIAL COMMITMENTS

The company has future operating lease commitments totalling £132,077.

9. ULTIMATE CONTROLLING PARTY

The controlling party is Medicorum Limited.